Mrs. Alyssa Johnson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 506 Reid Dr, Mount Horeb, WI 53572 Phone: 608-622-6846 |
Ms. Sarah Nguyen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 407 N 8th St, Mount Horeb, WI 53572 Phone: 608-437-9626 |
Mrs. Cheryl Elizabeth Hunt, OTR Occupational Therapist - Feeding, Eating & Swallowing Medicare: Not Enrolled in Medicare Practice Location: 9756 E Perry Center Rd, Mount Horeb, WI 53572 Phone: 608-437-3530 |
Betsy A Johnson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 407 N 8th St, Mount Horeb, WI 53572 Phone: 608-437-9626 |
Tricia Brown, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 311 Meadow View Rd, Mount Horeb, Mount Horeb, WI 53572 Phone: 920-912-2213 |
News Archive
Genta Incorporated announced that the Company has initiated treatment of the first subject in a new Phase 2 trial of tesetaxel in advanced melanoma. Tesetaxel is the Company's newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development. The new trial builds on more than ten years of Genta's experience in melanoma clinical research.
Independent workers - artists, journalists, information technology professionals, craftsmen and even those who earn their living buying and selling on eBay - will soon have the ability to buy health coverage without having to dicker with a privately-run insurance company such as Regence BlueCross BlueShield. ... people can sign up when enrollment opens for the health insurance exchange in October 2013.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload ADC technology, today announced the presentation of the first clinical data with the Company's IMGN853 product candidate.
Sanofi-aventis announced today that it has successfully completed its tender offer for all outstanding shares of common stock of Chattem, Inc..
› Verified 4 days ago